Exxon Mobil’s effort to build an energy trading business to compete with those of European oil majors unraveled quickly last…
ZURICH (Reuters) - Roche is filling a testing portfolio gap by buying U.S.-based GenMark Diagnostics in a $1.8 billion deal…